- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MERUS LABS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MPH HEALTH CARE | 29,200 | +1,39 % | HV-Kalender: u.a. AT&S, Baader, Delticom, Fielmann, Hornbach, Knaus Tabbert, MPH Health Care, Rubean, USU | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| EYEPOINT | 12,500 | +1,63 % | EyePoint, Inc.: EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU, Building Confidence Ahead of Mid-2026 Topline Data | - LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after - - Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously... ► Artikel lesen | |
| AMARIN | 13,000 | 0,00 % | Amarin Corporation plc: Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape | DUBLIN, Ireland and BRIDGEWATER, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease worldwide, applauds... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 11,950 | -0,83 % | DesignRush: Brooke Sellas Joins DesignRush Podcast on Social Media's Revenue Risk | Miami, Florida--(Newsfile Corp. - June 23, 2026) - The latest episode of the DesignRush Podcast features Brooke Sellas, founder and CEO of B Squared Media. The episode explores why companies risk... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 482,70 | -2,48 % | Suzhou Ribo Life Science Co., Ltd.: Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH | SUZHOU, China and MÖLNDAL, Sweden, July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 27,500 | -0,36 % | CATALYST PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| ANI PHARMACEUTICALS | 72,00 | 0,00 % | ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance | Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-yearPurified Cortrophin- Gel net revenues of $75.1 million, an increase of 42.1% year-over-yearQuarterly GAAP net income available... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript | ||
| DOGECOIN CASH | - | - | Dogecoin Cash, Inc.: Dogecoin Cash Files Utility Patent For Blockchain Infrastructure Designed To Support Dogecoin Application Usability | Mesquite, NV, June 15, 2026 (GLOBE NEWSWIRE) -- Mesquite, NV - June 15, 2026 - Dogecoin Cash, Inc. (OTC: DOGP) today announced the filing of a U.S. utility patent application with the United States... ► Artikel lesen | |
| BLUM HOLDINGS | - | - | BLUM HOLDINGS, INC. - 15-12G, Securities registration termination | ||
| THERIVA BIOLOGICS | 0,225 | -2,39 % | Theriva Biologics, Inc.: Theriva Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal | - VIRAGE2 exploratory study designed to refine dosing regimen to potentially improved outcomes in a future pivotal Phase 3 clinical trial -
- Study builds on positive clinical data from the recent... ► Artikel lesen | |
| BMP PHARMA TRADING | 6,950 | +12,10 % | PTA-News: B.M.P. Pharma Trading AG: Expansion nach Brasilien - B.M.P. AG gründet eine neue Gesellschaft in Sao Paulo zusammen mit einem lokalen Partner | DJ PTA-News: B.M.P. Pharma Trading AG: Expansion nach Brasilien - B.M.P. AG gründet eine neue Gesellschaft in Sao Paulo zusammen mit einem lokalen Partner
Unternehmensmitteilung für den Kapitalmarkt... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,050 | +4,74 % | Kazia Therapeutics Limited: Kazia Therapeutics Appoints James Levine as Chief Financial Officer | SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company... ► Artikel lesen | |
| ALLERGY THERAPEUTICS | 0,070 | -0,71 % | Allergy Therapeutics - Vesting of Options under Long-Term Incentive Plan | ||
| ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - 8-K, Current Report |
MERUS LABS INTERNATIONAL INC gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MERUS LABS INTERNATIONAL INC finden Sie auf Wallstreet Online.